ADHANSIA XR

Brand name authorized in: United States

Active ingredients

The drug ADHANSIA XR contains one active pharmaceutical ingredient (API):

1 Methylphenidate
UNII 4B3SC438HI - METHYLPHENIDATE HYDROCHLORIDE

Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space.

Read about Methylphenidate

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
US
FDA, National Drug Code
Identifier(s): 72912-525, 72912-535, 72912-545, 72912-555, 72912-570, 72912-585